Charles Gersbach
Corporate Officer/Principal bei Duke University
Profil
Charles Gersbach is the founder of Locus Biosciences, Inc. which was founded in 2015.
Currently, he is an Associate Professor at Duke University since 2009.
He previously worked as a Director at Element Genomics, Inc.
Aktive Positionen von Charles Gersbach
| Unternehmen | Position | Beginn |
|---|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.07.2015 |
Ehemalige bekannte Positionen von Charles Gersbach
| Unternehmen | Position | Ende |
|---|---|---|
Element Genomics, Inc.
 Element Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Element Genomics, Inc. engages in healthcare services. The company was founded in 2015 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
Element Genomics, Inc.
Element Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Element Genomics, Inc. engages in healthcare services. The company was founded in 2015 and is headquartered in Durham, NC. | Commercial Services |
